Eu Yan Sang International says wholly-owned subsidiary in Hong Kong, Eu Yan Sang (Hong Kong) Limited has acquired 90% interest in Yan Sang Biotechnology Company for HK$6.12 million ($1.03 million).

Yan Sang Biotechnology is incorporated in Macau with an issued and paid-up capital of $25,000 Macau Patacas ($4,090.64). The principal activities of Yan Sang Biotechnology are production, manufacture, wholesale and retail sale of proprietary Chinese medicine and health products.

None of the directors or substantial shareholders of the company has any interest, direct or indirect, in the above transaction, says Eu Yan Sang.